ANAVEX LIFE SCIENCES CORP. (NASDAQ:AVXL) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07.

On April 5, 2019, Anavex Life Sciences Corp., a Nevada corporation (the “Company”), held a special meeting of stockholders (the “Meeting”) as prescribed in the Proxy Statement filed by the Company with the Securities and Exchange Commission on February 11, 2019. At the Meeting, four proposals were submitted for a vote of the Company’s stockholders and the related results are as follows:

Proposal No. 1: The election of Christopher Missling, Ph.D., Athanasios Skarpelos, Elliot Favus, M.D., Steffen Thomas, Ph.D., Peter Donhauser, D.O., and Claus van der Velden, Ph.D. for terms until the next annual meeting of stockholders or until each such director’s successor shall have been duly elected and qualified. The stockholders elected each of the six directors by the following votes:

Proposal No. 2: Amendment of the Company’s Articles of Incorporation to Authorize Up To 10,000,000 Shares of Blank Check Preferred Stock. The stockholders approved the amendment of the Company’s Articles of Incorporation to authorize up to 10,000,000 shares of blank-check preferred stock of the Company as follows:

Proposal No. 3: Approval of Anavex Life Sciences Corp. 2019 Omnibus Incentive Plan. The proposal was approved as follows:

Proposal No. 4: Ratification of Independent Registered Public Accounting Firm. The stockholders ratified BDO USA, LLP as the Company’s independent registered public accounting firm as follows: